HERCEPTIN sous-cutané sol inj 600 mg/5 ml flac
7680659640012
CH-65964
L01FD01
07.16.1.
Reimbursement limitations:
HERCEPTINSC
Pour le traitement du cancer du sein HER2-positif au stade précoce.
1 / 3
google
Details
- Product number
- 6596401
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- trastuzumabum 600 mg, hyaluronidasum humanum ADNr, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, methioninum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 5 ml.
Articles (1)
Herceptin subkutan 600mg/5ml, Lösung zur subkutanen Injektion
Lösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
600.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1630.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2017
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 65964
- Drug name
- Herceptin subkutan, Lösung zur subkutanen Injektion
- Galenic form
- LSPA
- ATC Code
- L01FD01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 24/11/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- HERCEPTIN sous-cutané sol inj 600 mg/5 ml flac
- Description (DE)
- HERCEPTIN subkutan Inj Lös 600 mg/5 ml Durchstf
- Market launch
- 24/11/2016
- Narcotic (BTM)
- No